AMGN vs TEVA Stock Comparison
Compare AMGN and TEVA across AIQ Score, fundamentals, valuation, momentum, risk, analyst expectations and current market evidence.
What is the main difference between AMGN and TEVA?
AMGN leads the current stock comparison as Amgen Inc., with the clearest separation coming from quality and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Amgen Inc. vs Teva Pharmaceutical Industries Limited
AMGN leads
AMGN leads by 6 AIQ points, primarily on Quality and Momentum. Wall Street currently favors TEVA on target upside.
Fragile: 3 of 6 evidence groups support AMGN, and its current signal state is conflicted.
Amgen Inc.
Teva Pharmaceutical Industries Limited
The Algovestiq AIQ Score currently favors AMGN over TEVA, 58 versus 52 as of Sep 6, 2026. AMGN's advantage is driven primarily by stronger quality and momentum, while TEVA holds the stronger value profile. AMGN also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors TEVA. 3 of 6 covered evidence groups favor AMGN today, and the comparison is rated Fragile on stability: only 3 of 6 covered evidence groups agree. AMGN lead: Stable — the AIQ differential has held near 6 points over 30 sessions.
Compare Amgen Inc. and Teva Pharmaceutical Industries Limited across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Price-return comparison using available daily close history.
Total return comparison
Growth of $10,000
Based on available close-price history. Distribution reinvestment is not added unless already reflected in the source series.
Compare AMGN and TEVA against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Quality30%70 vs 33AMGN +37
- Value30%44 vs 65TEVA +21
- Momentum25%66 vs 60AMGN +6
- Risk Resilience15%50 vs 53Even
3 of 6 evidence groups favor AMGN. AMGN’s edge is concentrated in quality and momentum; TEVA keeps a meaningful value edge.
What changed since the last close
Latest scored session 2026-09-05, compared against the prior scored session 2026-09-04.
No factor moved materially.
No new signals fired.
No factor moved materially.
No new signals fired.
AMGN's lead was unchanged in the latest snapshot.
Deeper signal detail for each name lives on its own signals page — AMGN and TEVA both carry a full feed there.
The central trade-off
AMGN (Amgen Inc.): the stronger current systematic profile, led by quality and momentum.
TEVA (Teva Pharmaceutical Industries Limited): the counter-case, on value, valuation, analyst expectations — but at materially higher volatility, 28.3% against 22.1%.
The AIQ Score and Wall Street therefore point in different directions on this pair.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
AMGNAMGN on the overall AIQ Score, which weights Quality and Value at 30% each.
Growth
AMGNAMGN on combined revenue and EPS growth.
Value
TEVATEVA on the peer-relative Value factor, by 21 points.
Momentum
AMGNAMGN on the Momentum factor, by 6 points.
Lower downside
AMGNAMGN carries the lower 1-month annualized volatility.
Analyst upside
TEVATEVA on implied upside to the consensus price target.
AIQ vs Wall Street
The model and the Street disagree here: AIQ favors AMGN, analyst targets favor TEVA. That disagreement is the most useful thing on this page.
| Measure | AMGN | TEVA | Note |
|---|---|---|---|
| Implied upside to target | -13.9% | +18.3% | TEVA has more room |
| Target dispersion | +61.1% | +18.6% | Lower is tighter analyst agreement |
| Consensus | Hold | Buy | Context, not a primary driver |
| Analysts covering | 18 | 3 | Higher coverage generally improves confidence |
The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
3 of 6 covered evidence groups favor AMGN. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | AMGN | 58 vs 52 |
| Fundamentals | AMGN | revenue growth 16.7% vs 4%; EPS growth 30.6% vs -253.1%; TTM ROE 89.3% vs 9.2%; gross margin 72.7% vs 52.5%; operating margin 33.2% vs 14.9% |
| Valuation | TEVA | Value 44 vs 65 |
| Technicals | AMGN | Price vs 50-day 10.1% vs 5%; vs 200-day 22% vs 11.6% |
| Risk Resilience | Even | Risk Resilience 50 vs 53 |
| Analyst expectations | TEVA | Target upside -13.9% vs 18.3% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of AMGN and TEVA and are excluded from the count.
AIQ Decision Stability
The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.
- The AIQ gap is moderate at 6 points.
- Only 3 of 6 covered evidence groups agree. (argues the conclusion is provisional)
- The lead has been steady session to session. (supports the conclusion holding)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
- Analyst targets on the leader are widely dispersed. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on AMGN.
How the comparison changed
120 daily snapshots · Apr 24 – Sep 5AMGN lead: Stable — the AIQ differential has held near 6 points over 30 sessions.
- Today
- AMGN +6
- 58 vs 52
- 7 sessions ago
- AMGN +6
- 58 vs 52
- 30 sessions ago
- AMGN +7
- 63 vs 56
- 90 sessions ago
- AMGN +11
- 63 vs 52
The lead changed hands 2 times in this window, most recently on May 19 when AMGN moved ahead of TEVA.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
4 bullish / 1 bearish, conflicted
- Golden Cross Active — bullish, trend, long horizon (10.77%)
- EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
- 52-Week High Proximity — bullish, risk, long horizon (1.2%)
3 bullish / 1 bearish / 1 neutral, conflicted
- Golden Cross Active — bullish, trend, long horizon (6.26%)
- Bollinger Band Squeeze — neutral, volatility, short horizon
- EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
AMGN leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -1.55%, AIQ 0 points).
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -0.71%, AIQ 0 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1TEVA closes the Quality gap — currently 37 points behind, the largest single contributor to AMGN's edge.
- 2TEVA's Bollinger Band Squeeze turns directional — it is neutral today and would confirm a change in trend.
- 3AMGN's conflicting signal state resolves bearish — it currently carries 4 bullish and 1 bearish rules at once.
- 4A regime shift changes factor weighting — the composite weights Quality and Value at 30% each, so a rotation toward either would move the result most.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
AMGN leads on balance| Metric | AMGN | TEVA |
|---|---|---|
| Revenue growth (YoY) | 16.7% | 4% |
| EPS growth (YoY) | 30.6% | -253.1% |
| Gross margin | 72.7% | 52.5% |
| Operating margin | 33.2% | 14.9% |
| Return on equity (TTM) | 89.3% | 9.2% |
| Debt to equity | 4.9 | 2.16 |
Performance
AMGN leads 5 of 6 windows| Metric | AMGN | TEVA |
|---|---|---|
| 1 week (5 sessions) | 1.1% | -0.2% |
| 1 month (20 sessions) | 6.4% | 2.8% |
| 3 months (63 sessions) | 25.1% | 6.3% |
| 6 months (126 sessions) | 18.3% | 17.1% |
| Year to date | 33.6% | 16.5% |
| 1 year (252 sessions) | 54% | 93.8% |
Technicals
AMGN has the stronger structure| Metric | AMGN | TEVA |
|---|---|---|
| RSI (14) | 61.6 | 49.4 |
| ADX (14) | 43.2 | 33.1 |
| Price vs 50-day | 10.1% | 5% |
| Price vs 200-day | 22% | 11.6% |
| Volatility (1M, annualized) | 22.1% | 28.3% |
Risk
Split| Metric | AMGN | TEVA |
|---|---|---|
| Beta | 0.49 | 0.72 |
| Sharpe ratio | 1.61 | 1.8 |
| Sortino ratio | 3.11 | 3.9 |
| Max drawdown | -16.6% | -21.8% |
| Current drawdown | -1.6% | -4.6% |
| Annualized volatility | 27.7% | 39.9% |
| Value at risk (95%) | -2.3% | -3.2% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, AMGN or TEVA?
On the Algovestiq AIQ Score, AMGN is the stronger of the two as of Sep 6, 2026, scoring 58 against TEVA's 52. The edge comes from quality and momentum. TEVA is not without a case — it holds the better value profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is AMGN or TEVA the better buy right now?
AMGN carries the stronger systematic profile as of Sep 6, 2026, and the comparison is rated Fragile — 3 of 6 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: only 3 of 6 covered evidence groups agree. Treat the lead as provisional.
Why does the AIQ Score favor AMGN over TEVA?
The composite weights Quality at 30%, Value at 30%, Momentum at 25% and Risk Resilience at 15%. AMGN leads Quality by 37 points; TEVA leads Value by 21 points; AMGN leads Momentum by 6 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, AMGN or TEVA?
Analyst price targets imply -13.9% upside for AMGN and +18.3% for TEVA, so the Street currently favors TEVA. That points the opposite way to the AIQ Score, which favors AMGN. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, AMGN or TEVA?
TEVA is the better-valued of the two on the peer-relative Value factor. TEVA on the peer-relative Value factor, by 21 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, AMGN or TEVA?
AMGN on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, AMGN or TEVA?
AMGN on the Momentum factor, by 6 points. Momentum carries 25% of the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, AMGN or TEVA?
AMGN is the more resilient of the two, so the other name carries the higher downside risk. AMGN carries the lower 1-month annualized volatility. The Risk Resilience factor weights 15% of the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is AMGN more profitable than TEVA?
AMGN leads on the comparable margin measures — gross margin 72.7% vs 52.5%; operating margin 33.2% vs 14.9%; ttm roe 89.3% vs 9.2%.
Is AMGN's lead over TEVA getting stronger or weaker?
AMGN lead: Stable — the AIQ differential has held near 6 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-04-24 and 2026-09-05. The lead has changed hands 2 times in that window, most recently on 2026-05-19, when AMGN moved ahead of TEVA.
What would change the AMGN vs TEVA verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: TEVA closes the Quality gap — currently 37 points behind, the largest single contributor to AMGN's edge; TEVA's Bollinger Band Squeeze turns directional — it is neutral today and would confirm a change in trend; AMGN's conflicting signal state resolves bearish — it currently carries 4 bullish and 1 bearish rules at once; a regime shift changes factor weighting — the composite weights Quality and Value at 30% each, so a rotation toward either would move the result most.
What do the current signals say about AMGN and TEVA?
AMGN: 4 bullish / 1 bearish, conflicted. TEVA: 3 bullish / 1 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on AMGN is Golden Cross Active (bullish, long horizon). On TEVA it is Golden Cross Active (bullish, long horizon).
Compare AMGN and TEVA with others
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality (30%), Value (30%), Momentum (25%) and Risk (15%). Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.